Huan Qiu Wang·2025-06-09 01:25Group 1 - During the period from June 2 to June 6, 141 listed companies disclosed institutional research minutes, with over 70% of the companies experiencing positive stock performance, notably Jinling Sports with an increase of 88.24% [1] - Baili Tianheng attracted 136 institutional inquiries, focusing on its self-developed EGFRXHER3 dual-target ADC drug, iza-bren, which showed excellent data in lung cancer treatment, particularly in patients previously treated with PD-(L)1 inhibitors combined with platinum-based chemotherapy [3] - Zhongke Chuangda received 130 institutional inquiries, with a focus on its mobile robot product series, which has rapidly developed in scenarios such as latent robots, unmanned forklifts, and inspection robots, aiming to deepen its logistics and manufacturing sectors [3] Group 2 - Zhongqi New Materials addressed institutional concerns regarding industry integration and future asset acquisitions, indicating a structured approach to support the development of semiconductor materials and the integration of high-end equipment with existing materials business [4] - The company plans to enhance traditional materials technology and explore collaborations with Xingkong Technology to create synergistic effects [4]